Patient Centricity and Pharmaceutical Companies: Is It Feasible?

du Plessis, Danie; Sake, John-Kenneth; Halling, Katarina; Morgan, Jackie; Georgieva, Anna; Bertelsen, Neil

du Plessis, Danie; Sake, John-Kenneth; Halling, Katarina; Morgan, Jackie; Georgieva, Anna; Bertelsen, Neil.

Afiliación

du Plessis D; 1 Worldwide Medical Affairs, GlaxoSmithKline, London, United Kingdom.
Sake JK; 2 Medical Affairs, UCB, Brussels, Belgium.
Halling K; 3 Patient Reported Outcomes, AstraZeneca, Gothenburg, Sweden.
Morgan J; 4 Adelphi Group, Manchester, United Kingdom.
Georgieva A; 5 Excerpta Medica, Amsterdam, Netherlands.
Bertelsen N; 6 Neil Bertelsen Consulting, Berlin, Germany.

Ther Innov Regul Sci ; 51(4): 460-467, 2017 Jul.

Article en En | MEDLINE | ID: mdl-30227057

Palabras clave

drug discovery; patient centricity; patient-centered; patient-reported outcomes; pharmaceutical industry

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_technology_assessment Aspecto: Patient_preference Idioma: En Revista: Ther Innov Regul Sci Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google